Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities | Molecular Cancer | Full Text
Biological roles of hepatocyte growth factor‑Met signaling from genetically modified animals (Review)
Profiling YB-1 target genes uncovers a new mechanism for MET receptor regulation in normal and malignant human mammary cells | Oncogene
Targeting MET in Lung Cancer: Will Expectations Finally Be MET? - ScienceDirect
Targeting the MET gene for the treatment of non-small-cell lung cancer - ScienceDirect
Cancers | Free Full-Text | Activated HGF-c-Met Axis in Head and Neck Cancer | HTML
Highly accurate DNA-based detection and treatment results of MET exon 14 skipping mutations in lung cancer - Lung Cancer
Schematic structure of c-MET protein and the action sites of the... | Download Scientific Diagram
c-Met expression and activity in urogenital cancers – novel aspects of signal transduction and medical implications | Cell Communication and Signaling | Full Text
Frontiers | Selective Inhibitor of the c-Met Receptor Tyrosine Kinase in Advanced Hepatocellular Carcinoma: No Beneficial Effect With the Use of Tivantinib? | Immunology
c-Met expression in renal cell carcinoma with bone metastases - ScienceDirect
Abbreviations: MET, the receptor tyrosine kinase encoded by the... | Download Scientific Diagram
C-Met - Wikipedia
c-Met inhibitor - Wikipedia
Functional map and domain structure of MET, the product of the c-met protooncogene and receptor for hepatocyte growth factor/scatter factor | PNAS